George Gauthier is CCO at IGM Biosciences, Inc. (IGMS). They have made 6 open-market trades across 1 company since 2022, most recently 2023-11-29.
CIK 0001857434
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 6 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| IGMS | 39,642 | $50K |
Shares reported on the most recent Form 4, priced at the 2023-12-01 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| IGMS | SELL | 2023-11-29 | 2023-12-01 | $6.21 | $7K | +1.0% | +39.3% | +102.7% |
| IGMS | SELL · 10b5-1 | 2023-10-02 | 2023-10-03 | $7.95 | $7K | -33.3% | -28.4% | +31.3% |
| IGMS | SELL · 10b5-1 | 2023-07-03 | 2023-07-05 | $9.42 | $9K | +7.6% | -4.9% | -29.6% |
| IGMS | SELL | 2023-05-23 | 2023-05-25 | $12.31 | $15K | -6.9% | -20.9% | -30.5% |
| IGMS | SELL · 10b5-1 | 2023-04-05 | 2023-04-06 | $12.60 | $12K | -4.1% | +14.2% | -14.8% |
| IGMS | SELL | 2023-03-14 | 2023-03-16 | $18.73 | $20K | -10.3% | -36.0% | -45.1% |
| IGMS | SELL | 2022-12-16 | 2022-12-20 | $18.98 | $83K | -14.7% | +18.4% | -16.0% |
| IGMS | SELL | 2022-11-23 | 2022-11-28 | $21.57 | $27K | +3.7% | -19.9% | +7.5% |
| IGMS | SELL | 2022-05-24 | 2022-05-26 | $17.10 | $23K | +13.0% | +17.1% | +24.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.